Fibroblast Growth Factor 21 in Chronic Hepatitis C: A Potential Non-Invasive Biomarker of Liver Status upon Viral Eradication

Fibroblast Growth Factor 21 in Chronic Hepatitis C: A Potential Non-Invasive Biomarker of Liver Status upon Viral Eradication

Fibroblast growth factor 21 (FGF-21), previously recognized as a marker of liver damage and a potential drug target in non-alcoholic fatty liver disease (NAFLD), has unclear implications in hepatitis C virus (HCV) infections. This study aimed to investigate the relationship between FGF-21 levels and...

Full description

Bibliographic Details
Main Authors: Filippo Biagi, Francesco Carlomagno, Martina Carbone, Roberta Veralli, Umberto Vespasiani-Gentilucci, Elisabetta Riva, Silvia Manfrini, Dario Tuccinardi, Adriano De Santis, Lucio Gnessi, Mikiko Watanabe
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Metabolites
Subjects:
cirrhosis
DAAs
FGF-21
HCV
NAFLD
NASH
Online Access:https://www.mdpi.com/2218-1989/13/11/1119

Internet

https://www.mdpi.com/2218-1989/13/11/1119

Similar Items